| 000 | 01203 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250516045832.0 | ||
| 264 | 0 | _c20111115 | |
| 008 | 201111s 0 0 eng d | ||
| 022 | _a1699-3055 | ||
| 024 | 7 |
_a10.1007/s12094-011-0680-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoreno-Torres, Marta | |
| 245 | 0 | 0 |
_aBetween Scylla and Charibdis: eIF2α kinases as targets for cancer chemotherapy. _h[electronic resource] |
| 260 |
_bClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico _cJul 2011 |
||
| 300 |
_a442-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aEukaryotic Initiation Factor-2 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 700 | 1 | _aMurguía, José R | |
| 773 | 0 |
_tClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico _gvol. 13 _gno. 7 _gp. 442-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12094-011-0680-3 _zAvailable from publisher's website |
| 999 |
_c21022358 _d21022358 |
||